Cilofexor tromethamine

N/A

Report date: 2023/01/24 20:00:20
NME

Base Information

Drug NameCilofexor tromethamine
Drug Alias NamecilofexorGS-9674
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhenex Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesPhenex Pharmaceuticals Ag
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsFibrosisCholangitis, Sclerosing

Other Information

ATC CodeN/A
Related LinksN/A